|
Baricitinib and Cardiovascular Events
|
Baricitinib treatment does not increase the risk for cardiovascular problems in patients with rheumatoid arthritis, according to new research.
|
|
Read more
|
|
|
|
Tofacitinib and Cardiovascular Events
|
|
Rheumatoid arthritis patients taking tofacitinib could face some increased risks for significant cardiovascular events, depending upon their underlying characteristics, according to the results of a new study.
|
|
Read more
|
|
|
|
MORE FROM RHEUMATOLOGY NETWORK
|
|
|
|
The High Impact of Disease vs Financial Well-Being
|
|
Biologic DMARD Tapering Gets the Green Light in RA
|
|
Higher Risk of Cancer Recurrence Unlikely With TNFi Therapy in RA
|
